Literature DB >> 3196549

Predictive control by physical activity rate of a total artificial heart during exercise.

K Maeda1, T Chinzei, K Imachi, K Mabuchi, Y Abe, T Yonezawa, K Imanishi, I Fujimasa, K Atsumi.   

Abstract

No control method has yet been established for the total artificial heart (TAH) during exercise. As the simple intrinsic control method does not significantly increase cardiac output (CO), this study attempted to develop a new TAH control method that increases the CO during exercise in a manner similar to a natural heart (NH) by predicting changes in CO as a time function (TF) at various treadmill speeds. The control method for TAH was as follows: 1) an arbitrary grade of treadmill exercise was loaded onto the TAH goat; 2) a TF at this grade of treadmill exercise was determined from the physical activity rate (PAR) measurement, defined as the time average of the increase in vertical acceleration of the body; 3) operating parameters of both pumps were controlled in accordance with the TF using the computer algorithm. With the predictive control method changes in CO in the TAH were almost the same as in the NH, whereas no increase in CO occurred with the fixed control method (FC), in which operating parameters remained unchanged during exercise. Changes in blood lactate and catecholamines tended to be less than with the FC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196549

Source DB:  PubMed          Journal:  ASAIO Trans        ISSN: 0889-7190


  2 in total

1.  Identification algorithm for systemic arterial parameters with application to total artificial heart control.

Authors:  T L Ruchti; R H Brown; D C Jeutter; X Feng
Journal:  Ann Biomed Eng       Date:  1993 May-Jun       Impact factor: 3.934

Review 2.  Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities.

Authors:  Sara SantaCruz-Calvo; Leena Bharath; Gabriella Pugh; Lucia SantaCruz-Calvo; Raji Rajesh Lenin; Jenny Lutshumba; Rui Liu; Adam D Bachstetter; Beibei Zhu; Barbara S Nikolajczyk
Journal:  Nat Rev Endocrinol       Date:  2021-10-26       Impact factor: 43.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.